NCT01267955 2026-03-18
Vismodegib in Treating Patients With Advanced Chondrosarcomas
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Istituto Ortopedico Rizzoli
University of Iowa
Memorial Sloan Kettering Cancer Center
UNICANCER
Eli Lilly and Company